Tetrabenazine Tablet
Product Images NDC 70436-101

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 70436-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tetrabenazine-fig-01.jpg (Tetrabenazine Fig 01)

Line graph showing Chorea Score Change over Study Weeks comparing Tetrabenazine tablets and Placebo. The graph includes error bars and participant counts at the bottom, depicting a marked decrease in Chorea Score with Tetrabenazine relative to Placebo through weeks 0 to 12, with a washout period indicated at week 13.*

FDA Label Image

Tetrabenazine-insert-k02-01\tetrabenazine-fig-02.jpg (Tetrabenazine Fig 02)

A cumulative percentage line graph comparing Tetrabenazine tablets and placebo groups based on change from baseline in chorea score. The x-axis shows change from -16 to 6, and the y-axis shows cumulative percentage of patients from 0 to 100. Vertical reference lines mark points at -10, -6, and -3. A small table displays treatment group responses for change in total chorea score at -10, -6, and -3, with higher percentage improvements in the Tetrabenazine group.*

FDA Label Image

70436-101-09 (Tetrabenazine Label 1)

Tetrabenazine Tablets 12.5 mg label from Slate Run Pharmaceuticals, LLC. The label indicates a 112-tablet package, oral dosage form, and includes directions to dispense with a Medication Guide. Storage instructions specify 15° to 30°C. The label also displays NDC 70436-101-09, dosing caution, manufacturer details for Prami Pharma Limited in India, and a barcode.*

FDA Label Image

70436-102-09 (Tetrabenazine Label 2)

Tetrabenazine Tablets 25 mg oral dosage form packaging label from Slate Run Pharmaceuticals, LLC. The label displays the NDC 70436-102-09, bottle containing 112 tablets, with storage instructions and manufacturer information for Piramal Pharma Limited.*

FDA Label Image

Tetrabenazine-str-01.jpg (Tetrabenazine Str 01)

Chemical structure diagram of tetrabenazine showing its molecular arrangement including methoxy groups and a ketone functional group in a bicyclic ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.